Portal de Periódicos da CAPES

Mouse lymphoma thymidine kinase gene mutation assay: Follow‐up meeting of the international workshop on Genotoxicity testing—Aberdeen, Scotland, 2003—Assay acceptance criteria, positive controls, and data evaluation

2005; Wiley; Volume: 47; Issue: 1 Linguagem: Inglês

10.1002/em.20159

1098-2280

Martha M. Moore, Masamitsu Honma, Julie Clements, George Bölcsföldi, Brian Burlinson, Maria Grazia Cifone, Jane J. Clarke, Robert R. Delongchamp, Robert Durward, Michael Fellows, B. Bhaskar Gollapudi, Sai‐Mei Hou, Peter Jenkinson, Melvin Lloyd, Jenness B. Majeska, B. Myhr, Michael R. O’Donovan, Takashi Omori, Colin Riach, Richard H.C. San, Leon F. Stankowski, Ajit Kumar Thakur, Freddy Van Goethem, Shinobu Wakuri, Isao Yoshimura,

Computational Drug Discovery Methods

The Mouse Lymphoma Assay (MLA) Workgroup of the International Workshop on Genotoxicity Testing (IWGT), comprised of experts from Japan, Europe, and the United States, met on August 29, 2003, in Aberdeen, Scotland, United Kingdom. This meeting of the MLA Workgroup was devoted to reaching a consensus on the appropriate approach to data evaluation and on acceptance criteria for both the positive and negative/vehicle controls. The Workgroup reached consensus on the acceptance criteria for both the agar and microwell versions of the MLA. Recommendations include acceptable ranges for mutant frequency, cloning efficiency, and suspension growth of the negative/vehicle controls and on criteria to define an acceptable positive control response. The recommendation for the determination of a positive/negative test chemical response includes both the requirement that the response exceeds a defined value [the global evaluation factor (GEF)] and that there also be a positive dose-response (evaluated by an appropriate statistical method).